Skip to main content
. 2022 Aug 26;13:959938. doi: 10.3389/fphar.2022.959938

FIGURE 2.

FIGURE 2

Analysis of myricetin inhibition of lung cancer cells’ migration and invasion. Wound scratch assay of NCI-H446 and A549 cells treated with myricetin (30 μM) and its statistical analysis (A). (B)Migration analysis of myricetin (30 μM) -treated NCI-H446 and A549 cells. Western blot analyses of E-cadherin and Snail expression in NCI-H446 and A549 cells after myricetin (10 and 30 μM) treatment and their corresponding statistical analyses (C). The results were presented as mean ± standard deviation (****p < 0.0001, when compared with control).